Jupiter Neurosciences, Inc. (JUNS) Financials
JUNS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.7 million | 4.1 million |
| March 31, 2026 | 3.9 million | 6.7 million |
| Dec. 31, 2025 | 5.6 million | 7.4 million |
| Sept. 30, 2025 | 2.6 million | 2.5 million |
JUNS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.3 million | 490997 |
| March 31, 2026 | -1.4 million | 500992 |
| Dec. 31, 2025 | -2.4 million | -2.0 million |
| Sept. 30, 2025 | -1.2 million | 1.1 million |
JUNS Net Income
No data available :(
JUNS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 1.5 million | 205068 | 220607 |
| March 31, 2026 | 2.4 million | - | 8508 |
| Dec. 31, 2025 | 3.8 million | - | 21247 |
| Sept. 30, 2025 | 723797 | - | 33961 |
JUNS Shares Outstanding
JUNS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 600353 | 2.2 million | - |
| March 31, 2026 | - | 411049 | 1.6 million | - |
| Dec. 31, 2025 | - | -2.0 million | 2.8 million | - |
| Sept. 30, 2025 | - | 816697 | 1.5 million | - |
JUNS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 24245 | 3181 |
| March 31, 2026 | 18652 | 4362 |
| Dec. 31, 2025 | 21796 | - |
| Sept. 30, 2025 | - | - |
JUNS
Price: $2.90
52 week price:
Earnings Per Share: -18.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.2 million